Literature DB >> 14641652

Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy.

Alan R Berger1, Walter G Bradley, Thomas H Brannagan, Neil A Busis, Didier P Cros, Marinos C Dalakas, Moris J Danon, Peter Donofrio, W King Engel, John D England, Eva L Feldman, Roy L Freeman, Laurence J Kinsella, David Lacomis, Norman Latov, Daniel L Menkes, Howard W Sander, Florian P Thomas, William J Triggs, Anthony J Windebank, Gil I Wolfe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14641652

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN： 1085-9489            Impact factor:   3.494


× No keyword cloud information.
  11 in total

Review 1.  Molecularly targeted therapies for dysimmune neuropathies.

Authors:  Andreas A Argyriou
Journal:  Mol Med       Date:  2009-05-05       Impact factor: 6.354

2.  Tubercular neuritis: A new manifestation of an ancient disease.

Authors:  Kushal Naha; Mariya Joseph Dasari; Mukhyaprana Prabhu
Journal:  Australas Med J       Date:  2011-12-31

Review 3.  Chronic inflammatory demyelinating polyneuropathies: current treatment strategies.

Authors:  Thomas B Toothaker; Thomas H Brannagan
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

4.  Effect of age on the fractional anisotropy (FA) value of peripheral nerves and clinical significance of the age-corrected FA value for evaluating polyneuropathies.

Authors:  Keizo Tanitame; Yoshiko Iwakado; Yuji Akiyama; Hiroki Ueno; Kazuhide Ochi; Keiko Otani; Miyuki Takasu; Shuji Date; Kazuo Awai
Journal:  Neuroradiology       Date:  2011-11-24       Impact factor: 2.804

5.  Chronic inflammatory demyelinating polyneuropathy in a patient infected with human T lymphotropic virus type I.

Authors:  Amza Ali; Gurendra Char; Barrie Hanchard
Journal:  BMJ Case Rep       Date:  2009-08-20

6.  Diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy.

Authors:  Eduardo Adonias De Sousa; Thomas H Brannagan
Journal:  Curr Treat Options Neurol       Date:  2006-03       Impact factor: 3.972

7.  Autoimmune neuromuscular disorders.

Authors:  Jessica Kraker; Saša A Zivković
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

8.  A patient with amyotrophic lateral sclerosis and atypical clinical and electrodiagnostic features: a case report.

Authors:  Alexander Venizelos; Youngsook Park; Morris A Fisher
Journal:  J Med Case Rep       Date:  2011-11-02

9.  Challenges of clinical trial design when there is lack of clinical equipoise: use of a response-conditional crossover design.

Authors:  Chunqin Deng; Kim Hanna; Vera Bril; Marinos C Dalakas; Peter Donofrio; Pieter A van Doorn; Hans-Peter Hartung; Ingemar S J Merkies
Journal:  J Neurol       Date:  2011-08-07       Impact factor: 4.849

10.  Conduction slowing in diabetic sensorimotor polyneuropathy.

Authors:  Samantha K Dunnigan; Hamid Ebadi; Ari Breiner; Hans D Katzberg; Leif E Lovblom; Bruce A Perkins; Vera Bril
Journal:  Diabetes Care       Date:  2013-09-11       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.